What Evecxia’s EVX-301 trial reveals about the future of serotonin-based psychiatry
Evecxia’s Phase 1b study uses direct brain biomarkers to validate serotonin synthesis amplification. Find out why this matters for antidepressant development.
Pharma & Biotech